Lifeboat Foundation: Safeguarding Humanity
Toggle light / dark theme

Blog

Category: biotech/medical – Page 1662

“Eat your vitamins” might be replaced with “ingest your ceramic nano-particles” in the future as space research is giving more weight to the idea that nanoscopic particles could help protect cells from common causes of damage.

Oxidative stress occurs in our bodies when cells lose the natural balance of electrons in the molecules that we are made of. This is a common and constant occurrence that is part of our metabolism but also plays a role in the and several pathological conditions, such as heart failure, muscle atrophy and Parkinson’s disease.

The best advice for keeping your body in balance and avoiding oxidative stress is still to have a and eat enough vitamins, but nanoparticles are showing promising results in keeping cells in shape.

Read more | >

“Hotspots” of Coronavirus Infections in Human Bodies

An infection with the coronavirus SARS-CoV-2 can affect multiple organs. With this in mind, researchers of the German Center for Neurodegenerative Diseases (DZNE) and Cornell University in the US have investigated cellular factors that could be significant for an infection. To this end, they analyzed the activity of 28 specific genes in a wide range of human tissues. Their findings, which provide a map of potentially disease-relevant factors across the human body, are published in the journal Cell Reports.

“SARS-CoV-2 not just infects the respiratory system, it has the potential to affect many other organs in the body. Even if the virus infects the respiratory system first, it is essential to be able to predict where it might go next. This aids to develop therapies. Our goal was thus to learn more about what makes the different organs susceptible to infection,” explained Dr. Vikas Bansal, a data scientist at the DZNE’s Tuebingen site. “Therefore, we looked at different tissues to see which components of the cellular machinery might be relevant for infection and also which cell types appear to be particularly susceptible.” Bansal co-authored the current paper with Manvendra Singh, a Cornell presidential fellow, and with Cedric Feschotte, professor in the Department of Molecular Biology and Genetics at Cornell University.

Read more | >

What’s the risk of different human populations to develop a disease? To find out, a team led by Université de Montréal professor Guillaume Lettre created an international consortium to study the blood of hundreds of thousands of people worldwide.

In one of the largest studies of its kind, published today in Cell, close to 750,000 participants from five major populations—European, African, Hispanic, East Asian and South Asian—were tested to see the effect of on characteristics in their .

These characteristics include such things as hemoglobin concentration and platelet counts.

Read more | >

Sleep has critical roles in health and regeneration, and one of those is clearing the brain of metabolic waste, according to researchers from the US and Denmark.

Now, as reported in the journal Nature Communications, they’ve discovered in mice that the time of day matters, suggesting the process is controlled by circadian rhythms.

“Our group has shown that just being awake or asleep drastically changes how well the brain can clear waste,” says lead author Lauren Hablitz from the University of Rochester Medical Centre.

Read more | >

Melittin (MEL), a major peptide component of bee venom, is an attractive candidate for cancer therapy. This agent has shown a variety of anti-cancer effects in preclinical cell culture and animal model systems. Despite a convincing efficacy data against variety of cancers, its applicability to humans has met with challenges due to several issues including its non-specific cytotoxicity, degradation and hemolytic activity. Several optimization approaches including utilization of nanoparticle based delivery of MEL have been utilized to circumvent the issues. Here, we summarize the current understanding of the anticancer effects of bee venom and MEL on different kinds of cancers. Further, we also present the available information for the possible mechanism of action of bee venom and/or MEL.

Keywords: Bee venom, Melittin, Melittin conjugates, Cancer management, Anti-cancer effects.

Cancer is one of the major ailment effecting humankind and remains as one of the leading causes of mortality worldwide. The current available data suggests that over 10 million new patients are diagnosed with the disease every year and over 6 million deaths are associated with it representing roughly 12% of worldwide deaths. Fifteen million new cancer cases are anticipated to be diagnosed in the year 2020 [1] which will potentially increase to over 20 million by 2025 [2] and more in years to come. It is also anticipated that the growth and aging of the population may increase the new cancer cases to 21.7 million with about 13 million cancer deaths by the year 2030 [3].

Read more | >

Another bit of science fiction is coming to life as scientists develop a highly elastic and adhesive surgical glue similar to the one Ryan Gosling used to seal his wound in Blade Runner 2049.

Surgeons use sutures, staples, and wires (sometimes in combination with adhesive substances) to facilitate healing of external and internal wounds. These methods, however, are not optimal, especially for reconnecting contracting tissues like those of lungs, arteries and the heart.

Sutures are also not ideal for preventing the leaking of liquids from incisions. In addition, piercing tissues to place sutures can further damage the surrounding wound area and can increase the risk for infection.

Read more | >

The Buck Institute for Research on Aging scientists behind the research found that female mice that were fed enough AKG to maintain a younger mouse’s blood levels of the compound lived eight to 20 percent longer than the control group, according to research published Tuesday in the journal Cell Metabolism. On top of that, male and female mice who ate AKG had better fur color, stronger grips, and improved gait compared to others.

There’s a long and bumpy road between a successful mouse experiment and any sort of clinical applications for humans, but scientists are encouraged because AKG is already considered safe for humans to take.

“The big thing about this is that its safety profile is so good,” Holly Brown-Borg, a University of North Carolina aging researcher who didn’t work on the study told Science Magazine. “It has potential and should be explored further, for sure.”

Read more | >

Scientists have developed the most accurate computing method to date to reconstruct the patchwork of genetic faults within tumors and their history during disease development, in new research funded by Cancer Research UK and published in Nature Genetics.

Their powerful approach combines with the mathematical models of Charles Darwin’s theory of evolution to analyze genetic data more accurately than ever before, paving the way for a fundamental shift in how ’s genetic diversity is used to deliver tailored treatments to patients.

Applying these to DNA data taken from patient samples revealed that tumors had a simpler genetic structure than previously thought. The algorithms showed that tumors had fewer distinct subpopulations of cells, called “subclones,” than previously suggested. The scientists, based at The Institute of Cancer Research, London, and Queen Mary University of London, could also tell how old each subclone was and how fast it was growing.

Read more | >